The company manufactures custom, high-quality, synthetic DNA used by scientists to construct genes, pathways, genomes and organisms that will enable the next generation of breakthroughs in biology.
Founded by pioneering scientists in fabrication, genetics, and bio-engineering, Gen9 is democratizing synthetic biology. The goal is to enable broad adoption of powerful synthetic biology techniques by providing custom DNA constructs of the highest possible quality. Using its proprietary BioFab® platform, Gen9 simplifies design, ease to use, and access with synthetic DNA.
CEO Kevin Munnelly gave this illuminating overview at ABLC Next in San Francisco.